IBDEI0H3 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8300,0)
 ;;=346.11^^58^608^60
 ;;^UTILITY(U,$J,358.3,8300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8300,1,3,0)
 ;;=3^Migraine w/o Aura,Intractable
 ;;^UTILITY(U,$J,358.3,8300,1,4,0)
 ;;=4^346.11
 ;;^UTILITY(U,$J,358.3,8300,2)
 ;;=^336829
 ;;^UTILITY(U,$J,358.3,8301,0)
 ;;=346.20^^58^608^65
 ;;^UTILITY(U,$J,358.3,8301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8301,1,3,0)
 ;;=3^Migraine,Cluster,Not Intractable
 ;;^UTILITY(U,$J,358.3,8301,1,4,0)
 ;;=4^346.20
 ;;^UTILITY(U,$J,358.3,8301,2)
 ;;=^336877
 ;;^UTILITY(U,$J,358.3,8302,0)
 ;;=346.21^^58^608^64
 ;;^UTILITY(U,$J,358.3,8302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8302,1,3,0)
 ;;=3^Migraine,Cluster,Intractable
 ;;^UTILITY(U,$J,358.3,8302,1,4,0)
 ;;=4^346.21
 ;;^UTILITY(U,$J,358.3,8302,2)
 ;;=^336830
 ;;^UTILITY(U,$J,358.3,8303,0)
 ;;=346.80^^58^608^66
 ;;^UTILITY(U,$J,358.3,8303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8303,1,3,0)
 ;;=3^Migraine,Ophthalmic
 ;;^UTILITY(U,$J,358.3,8303,1,4,0)
 ;;=4^346.80
 ;;^UTILITY(U,$J,358.3,8303,2)
 ;;=^336878
 ;;^UTILITY(U,$J,358.3,8304,0)
 ;;=350.1^^58^608^37
 ;;^UTILITY(U,$J,358.3,8304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8304,1,3,0)
 ;;=3^Fifth Nerve Palsy
 ;;^UTILITY(U,$J,358.3,8304,1,4,0)
 ;;=4^350.1
 ;;^UTILITY(U,$J,358.3,8304,2)
 ;;=^121978
 ;;^UTILITY(U,$J,358.3,8305,0)
 ;;=351.9^^58^608^15
 ;;^UTILITY(U,$J,358.3,8305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8305,1,3,0)
 ;;=3^CN VII Palsy
 ;;^UTILITY(U,$J,358.3,8305,1,4,0)
 ;;=4^351.9
 ;;^UTILITY(U,$J,358.3,8305,2)
 ;;=^109776
 ;;^UTILITY(U,$J,358.3,8306,0)
 ;;=356.9^^58^608^101
 ;;^UTILITY(U,$J,358.3,8306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8306,1,3,0)
 ;;=3^Peripheral Neuropathy
 ;;^UTILITY(U,$J,358.3,8306,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,8306,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,8307,0)
 ;;=357.0^^58^608^43
 ;;^UTILITY(U,$J,358.3,8307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8307,1,3,0)
 ;;=3^Guillain-Barre Syndrome
 ;;^UTILITY(U,$J,358.3,8307,1,4,0)
 ;;=4^357.0
 ;;^UTILITY(U,$J,358.3,8307,2)
 ;;=^2622
 ;;^UTILITY(U,$J,358.3,8308,0)
 ;;=358.00^^58^608^69
 ;;^UTILITY(U,$J,358.3,8308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8308,1,3,0)
 ;;=3^Myasthenia Gravis
 ;;^UTILITY(U,$J,358.3,8308,1,4,0)
 ;;=4^358.00
 ;;^UTILITY(U,$J,358.3,8308,2)
 ;;=^329920
 ;;^UTILITY(U,$J,358.3,8309,0)
 ;;=363.01^^58^608^39
 ;;^UTILITY(U,$J,358.3,8309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8309,1,3,0)
 ;;=3^Focal Choroiditis/Choriorentinitis
 ;;^UTILITY(U,$J,358.3,8309,1,4,0)
 ;;=4^363.01
 ;;^UTILITY(U,$J,358.3,8309,2)
 ;;=^268664
 ;;^UTILITY(U,$J,358.3,8310,0)
 ;;=363.05^^58^608^70
 ;;^UTILITY(U,$J,358.3,8310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8310,1,3,0)
 ;;=3^Neuroretinitis
 ;;^UTILITY(U,$J,358.3,8310,1,4,0)
 ;;=4^363.05
 ;;^UTILITY(U,$J,358.3,8310,2)
 ;;=^268667
 ;;^UTILITY(U,$J,358.3,8311,0)
 ;;=367.21^^58^608^11
 ;;^UTILITY(U,$J,358.3,8311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8311,1,3,0)
 ;;=3^Astigmatism
 ;;^UTILITY(U,$J,358.3,8311,1,4,0)
 ;;=4^367.21
 ;;^UTILITY(U,$J,358.3,8311,2)
 ;;=^265371
 ;;^UTILITY(U,$J,358.3,8312,0)
 ;;=367.52^^58^608^77
 ;;^UTILITY(U,$J,358.3,8312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8312,1,3,0)
 ;;=3^Ophthalmoplegia,Internal
 ;;^UTILITY(U,$J,358.3,8312,1,4,0)
 ;;=4^367.52
 ;;^UTILITY(U,$J,358.3,8312,2)
 ;;=^265383
 ;;^UTILITY(U,$J,358.3,8313,0)
 ;;=367.53^^58^608^4
 ;;^UTILITY(U,$J,358.3,8313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8313,1,3,0)
 ;;=3^Accommodation,Spasm
 ;;^UTILITY(U,$J,358.3,8313,1,4,0)
 ;;=4^367.53
 ;;^UTILITY(U,$J,358.3,8313,2)
 ;;=^265378
